BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38184691)

  • 1. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
    Gouriou C; Lemanski C; Pommier P; Le Malicot K; Saint A; Rivin Del Campo E; Evin C; Quero L; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; de la Rocherfordiere A; Drouet F; Vendrely V; Lièvre A
    Br J Cancer; 2024 Mar; 130(5):769-776. PubMed ID: 38184691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
    Vendrely V; Lemanski C; Pommier P; LE Malicot K; Saint A; Rivin Del Campo E; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; Minsat M; Drouet F; Larrouy A; Peiffert D; Lievre A; Zasadny X; Hautefeuille V; Mornex F; Lepage C; Quero L;
    Radiother Oncol; 2023 Jun; 183():109542. PubMed ID: 36813175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
    Bacci M; Quero L; Barbier E; Parrot L; Juguet F; Pommier P; Bazire L; Etienney I; Baba-Hamed N; Spindler L; François E; Ronchin P; Campo ERD; Lemanski C; Lièvre A; Siproudhis L; Abramowitz L; Lepage C; Vendrely V
    Dig Liver Dis; 2021 Jun; 53(6):776-784. PubMed ID: 33867291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
    Evin C; Quéro L; Le Malicot K; Blanchet-Deverly S; Evesque L; Buchalet C; Lemanski C; Hamed NB; Rivin Del Campo E; Bauwens L; Pommier P; Lièvre A; Gouriou C; Tougeron D; Macé V; Sergent G; Diaz O; Zucman D; Mornex F; Locher C; De la Rochefordière A; Vendrely V; Huguet F
    Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38912999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial.
    Vendrely V; Ronchin P; Minsat M; Le Malicot K; Lemanski C; Mirabel X; Etienne PL; Lièvre A; Darut-Jouve A; de la Fouchardière C; Giraud N; Breysacher G; Argo-Leignel D; Thimonnier E; Magné N; Abdelghani MB; Lepage C; Aparicio T;
    Radiother Oncol; 2023 Sep; 186():109742. PubMed ID: 37315583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
    Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
    BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Outcomes With Dose Escalation Using Modern Radiotherapy Techniques: A Retrospective Review of Anal Cancer Treated at a Large Academic Institution Between 2010 and 2016.
    Murchison SC; DeVries KJ; Atrchian S
    Cureus; 2020 Oct; 12(10):e10989. PubMed ID: 33209545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
    Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
    Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of anal cancer patients at the Ottawa hospital.
    Abunassar M; Reinders J; Jonker DJ; Asmis T
    Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
    Eng C; Jácome AA; Das P; Chang GJ; Rodriguez-Bigas M; Skibber JM; Wolff RA; Qiao W; Xing Y; Sethi S; Ohinata A; Crane CH
    Clin Colorectal Cancer; 2019 Dec; 18(4):301-306. PubMed ID: 31350201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
    Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
    Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
    Atallah RP; Zhang Y; Zakka K; Jiang R; Huang Z; Shaib WL; Diab M; Akce M; Wu C; El-Rayes BF; Alese OB
    J Gastrointest Oncol; 2022 Oct; 13(5):2306-2321. PubMed ID: 36388688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of radical radiotherapy combined with different regimens of chemotherapy on radiation intestinal injury in patients with non-metastatic anal squamous cell carcinoma].
    Pang XL; Liu S; Liu YP; Chen HY; He F; Zheng J; Wan XB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):977-983. PubMed ID: 34823298
    [No Abstract]   [Full Text] [Related]  

  • 14. Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
    Kim S; Meurisse A; Spehner L; Stouvenot M; François E; Buecher B; André T; Samalin E; Jary M; Nguyen T; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; de la Fouchardiere C; Boulbair F; Lakkis Z; Klajer E; Jacquin M; Taieb J; Vendrely V; Vernerey D; Borg C
    Ther Adv Med Oncol; 2020; 12():1758835920975356. PubMed ID: 33329760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.
    Untiedt S; Rolf D; Scobioala S; Wolters H; Elsayad K; Oertel M; Kittel C; Pascher A; Rijcken E; Ullerich H; Glasbrenner B; Eich HT
    Strahlenther Onkol; 2023 Aug; 199(8):749-760. PubMed ID: 36862155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.
    Kim KH; Chang JS; Keum KC; Ahn JB; Lee CG; Koom WS
    Radiat Oncol J; 2013 Mar; 31(1):25-33. PubMed ID: 23620866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
    Kim S; Buecher B; André T; Jary M; Bidard FC; Ghiringhelli F; François É; Taieb J; Smith D; de la Fouchardière C; Desramé J; Samalin E; Parzy A; Baba-Hamed N; Bouché O; Tougeron D; Dahan L; El Hajbi F; Jacquin M; Rebucci-Peixoto M; Spehner L; Vendrely V; Vernerey D; Borg C
    BMC Cancer; 2020 Apr; 20(1):352. PubMed ID: 32334548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C.
    White EC; Goldman K; Aleshin A; Lien WW; Rao AR
    Radiother Oncol; 2015 Nov; 117(2):240-5. PubMed ID: 26347494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
    Bentzen AG; Guren MG; Wanderås EH; Frykholm G; Tveit KM; Wilsgaard T; Dahl O; Balteskard L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e173-80. PubMed ID: 22436791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.